| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/25/2004 | WO2003014301A3 Hprp4s as modifiers of the p53 pathway and methods of use |
| 03/25/2004 | WO2003008647A3 Blood assessment of injury |
| 03/25/2004 | WO2003006103A3 Electrical field stimulation of eukaryotic cells |
| 03/25/2004 | WO2002097441A3 Mammalian diabetes-mediating proteins |
| 03/25/2004 | WO2002095065A3 G-protein coupled receptor arrays |
| 03/25/2004 | WO2002092780A3 Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof |
| 03/25/2004 | WO2002090598A3 Methods for the identification of inhibitors of flavanone 3-hydroxylase expression or activity in plants |
| 03/25/2004 | WO2002089832A3 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 03/25/2004 | WO2002086050A3 Ion channel polynucleotide arrays comprising non-conserved regions identifying ion channel family member expression profiles |
| 03/25/2004 | WO2002085093A3 Replikin peptides and uses thereof |
| 03/25/2004 | WO2002083859A8 Surface proteins of streptococcus pyogenes |
| 03/25/2004 | WO2002079492A8 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators |
| 03/25/2004 | WO2002074048A3 P-glycoproteins and uses thereof |
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |
| 03/25/2004 | WO2002059357A3 Assay and kit for analyzing gene expression |
| 03/25/2004 | WO2002059321A3 Hepatitis c virus replicons and replicon enhanced cells |
| 03/25/2004 | WO2002057789A8 Test for transmissible spongiform encephalopathies |
| 03/25/2004 | WO2002057496A3 Gene expression profiling of endothelium in alzheimer's disease |
| 03/25/2004 | WO2002044342A3 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 03/25/2004 | WO2002014862A8 Method and device for characterising and/or for detecting a bonding complex |
| 03/25/2004 | WO2001051007A3 Nuclear packing efficiency |
| 03/25/2004 | US20040060087 Chimeric progeny of nicotiana excelsior and nicotiana benthamiana for generation of enhanced properties and biomass; bioreactor for expression of heterologous proteins |
| 03/25/2004 | US20040060086 Interspecific nicotiana hybrids and their progeny |
| 03/25/2004 | US20040059519 Multiplexed analysis of clinical specimens apparatus and methods |
| 03/25/2004 | US20040059089 Comprises receptor protein for controlling gene expression in transgenic cells; for diagnosis, prevention and treatment of heart, tumor and urogenital disorders |
| 03/25/2004 | US20040059087 Peptide nucleic acids |
| 03/25/2004 | US20040058884 Detecting diseases by Selex method; anticancer agents |
| 03/25/2004 | US20040058876 Secondary binding site of dipeptidyl peptidase IV (DP IV) |
| 03/25/2004 | US20040058869 Methods and reagents for modulating cholesterol levels |
| 03/25/2004 | US20040058868 Using insulin receptor substrate and histone deacetylase inhibitor; regenerating insulin sensitivity |
| 03/25/2004 | US20040058853 Multivalent neuraminidase inhibitor conjugates |
| 03/25/2004 | US20040058457 Nucleic acid nanoparticle complex comprising peptide ligand for use electronic, optics, genomics, proteomics, and biomedical analysis; microarray chips |
| 03/25/2004 | US20040058433 Metal electrodes has a surface that is modified with a surface modification layer made up of linera molecules having sufhydryl end group and a sulfonate end group separated by lower alkyl linking group |
| 03/25/2004 | US20040058427 Herbicide resistant plants |
| 03/25/2004 | US20040058424 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/25/2004 | US20040058417 Covalent joining of DNA to RNA by vaccinia topoisomerase and uses thereof |
| 03/25/2004 | US20040058409 Micro-oraganisms with glycosylation modulating action of intestinal cell surface |
| 03/25/2004 | US20040058406 Assay methods and systems |
| 03/25/2004 | US20040058399 Evaluating effectiveness of isoniazid preventive therapy in treating tuberculosis |
| 03/25/2004 | US20040058398 Pancreatic progenitor cells and methods for isolating the same |
| 03/25/2004 | US20040058396 Methods for the screening of non-recombinant cell lines capable of expressing a single PDE4 isoenzyme and for the screening of PDE4 inhibitors |
| 03/25/2004 | US20040058388 Quality assurance/quality control for high throughput bioassay process |
| 03/25/2004 | US20040058385 Kit and method for determining multiple analytes, with provisions for refrencing the density of immobilised recognition elements |
| 03/25/2004 | US20040058378 Using DNA binding protein to stabilize polynucleotides during exponential and selective propagation of target nucleotide sequences; forensics, medicine and agriculture |
| 03/25/2004 | US20040058376 Using microarray to identify gene networks and anticarcinogenic agents; genetic mapping and gene expression; diagnosing cancer |
| 03/25/2004 | US20040058375 Genetically filtered shotgun sequencing of complex eukaryotic genomes |
| 03/25/2004 | US20040058374 Method for mixing nucleic acid with a water insoluble medium and appalication thereof |
| 03/25/2004 | US20040058373 Competitive amplification of fractionated targets from multiple nucleic acid samples |
| 03/25/2004 | US20040058372 Initializing control model for monitoring spectral data from bioinformatics system |
| 03/25/2004 | US20040058368 M-GAL: a Gal gene switch-based suite of methods protein analyses and protein expression in multicellular organisms and cells therefrom |
| 03/25/2004 | US20040058366 Comprises DNA coding brain-muscle-arnt-like protein 2 (BMAL2) for diagnosis and treatment of circadian rythm disorders |
| 03/25/2004 | US20040058364 Modified nucleotides and methods useful for nucleic acid sequencing |
| 03/25/2004 | US20040058363 Using presence of restriction fragment length polymorphism in udp-glucuronosyltransferase (UGT) gene to predict site effect reductions to irinotecan exposure |
| 03/25/2004 | US20040058362 Polymerase chimeras |
| 03/25/2004 | US20040058361 Antibacterial treatments |
| 03/25/2004 | US20040058360 Selecting, accumulating, precipitating and recovering small copy number nucleotide sequences; nucleic acid precipation |
| 03/25/2004 | US20040058359 Erbin as a negative regulator of Ras-Raf-Erk signaling |
| 03/25/2004 | US20040058358 Lipid metabolism transcription factor |
| 03/25/2004 | US20040058357 Comparing the effect of a test drug on AChE catalytic activity or isoform variance in the brain of a test animal following challagene by AChE blocker or a blocker of AChE and muscarinic receptors M1 and M2 |
| 03/25/2004 | US20040058356 Identifying promoter sequences for use as tools in gene transfer and genetic engineering |
| 03/25/2004 | US20040058355 Comprises nucleotide sequences coding membrane proteins for diagnosis and treatment of brain, breast disorders, colon, kidney, inflammatory, brain and urogenital disorders |
| 03/25/2004 | US20040058353 Comprises nucleotide sequences coding transport proteins for diagnosis and treatment of pain, psychotic, eating and nervous system disorders |
| 03/25/2004 | US20040058352 Method of establishing resistance profiles of tissues and cell lines |
| 03/25/2004 | US20040058351 Method of examining for allergic disease |
| 03/25/2004 | US20040058349 Methods for identifying nucleotides at defined positions in target nucleic acids |
| 03/25/2004 | US20040058344 Transgenic cells comprising precursor messenger RNA for diagnosis of infectious, cell proliferative, nervous system and metabolic disorders |
| 03/25/2004 | US20040058342 Comprises serine protease for diagnosis, prognosis and treatment of cell proliferative disorders |
| 03/25/2004 | US20040058341 Protein phosphatases |
| 03/25/2004 | US20040058340 Diagnosis and prognosis of breast cancer patients |
| 03/25/2004 | US20040058339 Method for detecting polynucleotide sequences |
| 03/25/2004 | US20040058337 Process for determining the tumorcidal potential of a sample the use of a nucleic acid which is downregulated in human tumor cells |
| 03/25/2004 | US20040058336 Detection of vancomycin-resistant enterococcus spp. |
| 03/25/2004 | US20040058335 Detecting molecular binding by monitoring feedback controlled cantilever deflections |
| 03/25/2004 | US20040058334 Using microsatelite sequences and homologous genetic exchange diagnose fibrodysplasia ossificans progressiva |
| 03/25/2004 | US20040058332 Real-time PCR assay of the bacterium Edwardsiella ictaluri in channel catfish |
| 03/25/2004 | US20040058331 Blood testing method, testing chip, and testing device |
| 03/25/2004 | US20040058330 Using thermophilic synthetases to prepare and replicate preferential nucleotide sequences; primer, probe and complimentary DNA biosynthesis |
| 03/25/2004 | US20040058328 Using oligonucleotide probes for detection, identification and/or sequencing of nucleic acids and/or biomolecules; for use in medical diagnostics, forensics, toxicology, pathology, biological warfare |
| 03/25/2004 | US20040058326 Identification and use of molecules implicated in pain |
| 03/25/2004 | US20040058325 Using tumor marker transcription patterns to diagnose, prognose and treat colon cancer |
| 03/25/2004 | US20040058323 Proteins with repetitive bacterial-Ig-like (big) domains present in leptospira species |
| 03/25/2004 | US20040058322 Conjugates between a minor groove binding the trimer of 1,2-dihydro- (3H)-pyrrolo(3,3-e)indole-7-carboxylate and an oligonucleotide and forms stable hybrids with complementary target sequence |
| 03/25/2004 | US20040058321 Comprises nucleotide sequences coding transforming growth factor binding proteins for diagnosis and treatment of osteoporosis and osteopenia |
| 03/25/2004 | US20040058320 Reagents and methods for identifying and modulating expression of tumor senescence genes |
| 03/25/2004 | US20040058319 Comprises nucleotide sequences coding urogenital polypeptide for diagnosis and treatment cancer |
| 03/25/2004 | US20040058318 Transcripton factor comprising tyrosine kinase and interferon binding domains for diagnosis and treatment of autoimmune and immune response disorders; imunosuppressants |
| 03/25/2004 | US20040058317 Using high throughput assay to detect restriction fragment length polymorphisms in gene coding mannose binding protein |
| 03/25/2004 | US20040058315 Influenza sensor |
| 03/25/2004 | US20040058314 Assay for the detection and quantification of HBV cccDNA by real-time PCR |
| 03/25/2004 | US20040058313 Using gabapentim to relieve external pressure and improve glaucoma treatments; neuroprotectants and eye surgery; neurotoxins and vision defects |
| 03/25/2004 | US20040058312 Method to identify environmental contamination by detecting enteric viruses |
| 03/25/2004 | US20040058311 Method and apparatus for measuring the hemoglobin concentration and/or hematocrit in whole blood using diffuse light |
| 03/25/2004 | US20040058021 Which suppresses I-kappa-B-alpha phosphorylation through inhibition kinase activity and downregulating NF-kappa-B; antiproliferative agents |
| 03/25/2004 | US20040057963 Therapeutic TB vaccine |
| 03/25/2004 | US20040057943 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 03/25/2004 | US20040057930 Method for the development of an HIV vaccine |
| 03/25/2004 | US20040057871 Functional assay of high-density lipoprotein |
| 03/25/2004 | US20040055956 Includes valving to enable the excess diluent to move from the purification column into the output reservoir to provide removed diluent |
| 03/25/2004 | US20040055898 Analytical sensors for the detection of bioanalytes in a small volume sample |
| 03/25/2004 | US20040055885 Biosensor |